Can endometrial arylsulfatase A activity predict the onset of endometrial polyps over the years? by Indraccolo U et al.
Can endometrial arylsulfatase A activity 
predict the onset of endometrial polyps over 
the years?
A atividade da arilsulfatase endometrial A pode prever a aparição de 
pólipos endometriais ao longo dos anos?
Ugo Indraccolo1
MarIa Matteo2
carla BracalentI3
Pantaleo greco2
Salvatore renato Indraccolo4
Abstract
PURPOSE: To assess if arylsulfatase A activity (ASA) and sulfatide (SL) concentration in the human endometrium can be 
predictive of the development of endometrial polyps over the years, since ASA activity reflects the endometrial sensitivity 
to hormones. METHODS: ASA activity and SL concentration were determined by biochemical procedures on endometrial 
samples collected between 1990 and 1994 in non-menopausal women. These women underwent a new endometrial 
sampling following the clinical indication some years after the first endometrial sampling. The histological assessment 
of the second endometrial specimens found four patients with normal endometrial pattern and 10 patients with one or 
more endometrial polyps. ASA activity/years elapsed and SL concentration/years elapsed were compared using two 
tailed Mann-Whitney test for unpaired data between patients with normal pattern and patients with endometrial polyps. 
RESULTS: Median ASA activities were 2.62 (normal pattern) versus 1.85 (endometrial polyps) nmol hydrolized substrate/
min. Median activity/years elapsed is higher in patients with second endometrial sample presenting normal pattern 
(p=0.006) and median SL concentration/years elapsed does not differ significantly among groups, even if median SL 
concentration seems to be higher in patients who subsequently developed polyps (1031 μg/g of fresh tissue versus 
341,5 μg/g of fresh tissue). CONCLUSIONS: ASA activity can predict the onset of endometrial polyps over the years.
Resumo
OBJETIVO: Avaliar se a atividade da arilsulfatase A (ASA) e a concentração de sulfatida (SL) no endométrio humano 
pode ser preditivo em relação ao desenvolvimento de pólipos endometriais ao longo dos anos, posto que atividade 
da ASA reflete a sensibilidade do endométrio aos hormônios. MÉTODOS: A atividade da ASA, assim como a 
concentração de SL, foi determinada por meio de procedimentos bioquímicos em amostras de endométrio coletadas 
entre 1990 e 1994, em mulheres que não se encontravam na menopausa. Essas mulheres foram submetidas a uma 
nova amostragem endometrial após indicação clínica alguns anos depois da primeira amostragem endometrial. 
A avaliação histológica dos segundos espécimes endometriais permitiu identificar quatro pacientes com padrão 
endometrial normal e 10 com um ou mais pólipos endometriais. A atividade da ASA/anos depois e a concentração 
de SL/anos depois foram comparadas, utilizando o teste bilateral U de Mann-Whitney para dados não pareados 
entre as pacientes com padrão normal e as pacientes com pólipos endometriais. RESULTADOS: A ativitade da ASA 
foi 2,62 (padrão normal) em comparação com 1,85 (endometrial pólipos) de substrato hidrolisado/min. A atividade 
da ASA/anos depois é maior em pacientes com segunda amostra endometrial a apresentarem um padrão normal 
(p=0,006), e a concentração mediana de SL/anos depois não difere de forma significativa entre os grupos, apesar 
de a concentração mediana de SL parecer maior em pacientes que posteriormente desenvolveram pólipos (1031 μg/g 
de tecido fresco em comparação com 341,5 μg/g de tecido fresco). CONCLUSÕES: A atividade da ASA pode 
prever a aparição de pólipos endometriais ao longo dos anos.
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Introduction 
Endometrial behavior during the menstrual cycle is 
closely related to the expression of hormonal receptors 
in the glandular epithelium and stroma1. As opposed to 
patients with normal cycles, patients with dysfunctional 
bleeding have higher levels of estrogen receptors in the 
second phase of the cycle2, which suggests that their en-
dometrium is more susceptible to estrogen stimulation. 
It is thought that endometrial polyps may be related 
in some ways to hyperestrogenism both in premenopausal 
and postmenopausal patients3. Therefore, patients with 
dysfunctional bleeding, more sensitive to estrogens2, may 
develop endometrial polyps over the years in relation to 
endometrial estrogen sensitivity and to the duration of 
estrogen stimulation of endometrium. 
Many genes are expressed in the endometrium during 
the menstrual cycle in relation to hormonal stimulation, 
with the goal to prepare the endometrium for implantation4. 
Arylsulphatase A (ASA) expression is regulated by estrogens 
and progesterone, because estrogens decrease ASA activity and 
progesterone increases it5-8. ASA is a lysosomal enzyme that 
catabolizes sulphatides (SL). To date, it is not known what 
role SL plays in the physiology of the endometrium. 
The objective of this study is to evaluate whether ASA 
activity and SL concentration can predict the onset of endo-
metrial polyps over the years, because hormonal control of 
ASA activity is a marker of  endometrial hormonal sensitivity. 
Methods
Starting in 1990, a study on endometrial specimens 
collected at the Obstetrics School of Camerino (Italy) 
was initiated. The research aimed to assess ASA activity 
and SL concentration in normal endometrium through 
the endometrial cycle and in endometrial pathologies, 
and results were published in 1992 and 19946,9. Such 
analyses were previously approved by local ethics commit-
tees. Among samples collected between 1990 and 1994, 
some cases were excluded from data published in 1992 
and 19946,9 because patients did not meet the inclusion 
criteria. However, ASA activity and SL concentration 
were nonetheless assessed on such specimens.
The names and birth dates of the excluded non-
menopausal patients and the names and birth dates of 
non-menopausal patients enrolled in previous studies6,9 
were transmitted to the Operative Unit of Pathology of 
the hospital of Macerata (Area Vasta 3 – 3  Marche). Here, 
it was observed whether or not some of these patients had 
undergone another endometrial biopsy, collected between 
1995 and 2011. Therefore, this is a  retrospective study. 
The search retrieved 14 cases, four of which had normal 
endometrium, and 10 of which had endometrial polyps. 
ASA activity and SL concentration analyzed on en-
dometrial specimens collected from 1990 and 1994 were 
compared in the group of patients with negative endo-
metrium in the subsequent endometrial samples and in 
the group of patients who developed endometrial polyps. 
To control the effect of time (years) between the first and 
the second endometrial sample, ASA activity and SL con-
centration were divided by the years elapsed between the 
two samplings, to obtain an index for statistical analysis. 
Two tailed Mann-Whitney test for unpaired data was used 
for statistical analysis, with p<0.05 as the minimum for 
significance. Kyplot 2.0 was used for statistical analysis. 
The specimens collected from 1990 to 1994 were 
obtained after dilatation and curettage (D&C). A portion 
of each sample was processed for histological diagnosis; 
the other portion was stored at -20°C. Extraction and 
separation of sulfatides were carried out according to a 
method adapted from Bolognani et al.10: The samples 
were homogenized in chloroform/methanol (2:1 w/v) 
and  the extract was filtered though a sintered glass with 
a vacuum pump connection. KCl (0.88%) was added to 
the filtrate and, after stirring, the covered tube was left 
until the separation phase (aqueous and organic phase) 
occurred. The organic phase was analyzed by means of 
a spectrophotometric procedure for sulfatides, using a 
0.15 mm Azure A solution in 0.05 N H2SO4 for stain-
ing11. Absorbance was measured at 640 nm against a 
standard containing 70 mg/g of sulfatides. Concentration 
was expressed as μg/g of fresh tissue.
The organic phase was also used for thin layer chro-
matography (TLC) separation on a 0.25 mm silica gel 
plate. Lipids were separated on the same plate using a 
solvent mixture of chloroform-methanol-water (70:30:5 
per volume) and compared with a standard polar lipid 
mixture (phosphatidylcholine, sulfatides, phosphatidyl-
ethanolamine and cerebrosides). The plates were exposed 
to iodine vapours to visualize the lipid fractions in order 
to quantify sulfatide concentration.
To assess ASA activity, samples were homogenized for 
2 minutes in double distilled water (1:20 w/v) contain-
ing 0.1% Triton versus 100 with Ultraturrax TP 18/10 
homogenizer (Janke & Kunkel, Staufen, Germany). The 
homogenate was centrifuged at 20,000 rpm at 4°C for 
30 minutes using a refrigerated centrifuge (IEC Centra 
SR, Dunstable, Bedfordshire, England). ASA activity 
was determined biochemically according to a method 
by Vitaioli et al.12, adapted from Percy and Brady13. The 
incubation mixture consisted of 0.01 M p-nitrocatechol 
sulfate in 0.5 mM sodium acetate buffer at pH 5.0 con-
taining mM Na
4
P
2
O
7
, and 10% w/v NaCl, and 10–50 mg 
of protein. The mixture was incubated at 37°C and the 
reaction stopped after 30 minutes by adding 1 N NaOH. 
The absorbance of a reaction product, p-nitrocatechol, was 
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measured at 515 nm against a blank using a Beckman DU 
40 spectrophotometer (Irvine, USA). The specific activ-
ity was expressed as nmol hydrolysed substrate/min per 
mg protein, assuming 14.0 x 103 as the molar extinction 
coefficient for the hydrolysis product, p-nitrocatechol, 
of the substrate at 515 nm. Protein concentrations were 
measured according to the Bradford’s14 method.
P-nitrocathecol sulfate and standard polar lipids mix-
ture were purchased from Sigma Aldrich Chemical Co. (St. 
Louis, MO). All other chemicals were of analytical grade 
and were purchased from Serva (Heidelberg, Germany). 
The 0.25 mm precoated silica gel plates, used for TLC, 
were purchased from Merck Co. (Dormstadt, Germany).
Endometrial samples taken between 1995 and 2011 
were obtained from hysteroscopic biopsies as a routine 
endometrial assessment for irregular bleeding or ultra-
sonographic suspicion of endometrial diseases within the 
entire health district of Area Vasta 3 – Marche.
Results
Table 1 summarizes histological diagnoses for the first 
and second endometrial specimens. Additionally, Table 1 
reported the patient’s age at the first endometrial sampling 
and the years elapsed from first sampling to second. ASA 
activities and SL concentrations reported in Table 1 are 
the mean of four determinations for each patient.
Median ASA activity in patients with the second 
endometrial sample resulting in normal pattern was 
2.6 nmol hydrolized substrate/min (limits: 2.28–3.23). 
Median ASA activity in patients with the second en-
dometrial sample diagnosed as endometrial polyp was 
1.85 nmol hydrolized substrate/min (limits: 0.6–3.4). 
A box-plot describing ASA activities in both groups of 
patients is represented in Figure 1. After correction for 
years elapsed from the first and the second endometrial 
sampling, median ASA activity/years elapsed is higher in 
Table 1. Descriptive data
Age at  time of  first biopsy
(median–limits)
Histological diagnoses 
(between 1990–1994)
(rates)
ASA
activity*
(mean±SD)
SL
concentration**
(mean±SD)
Histological diagnoses 
(after 1994)
(rates)
Years elapsed from first 
endometrial sampling to 
second 
(median–limits)
43.5
37–52
Simple non atypical hyperplasia
14.3%
2.19±0.76 760.14±355.01
Normal patterns
28.6%
6.5
4–15
Dysfunctional endometrium
21.4%
Endometrial polyps
71.4%
Proliferative endometrium
28.6%
Secretive endometrium
7.1%
Endometrial polyps
21.4%
*ASA (Arylsulphatase A) activity is expressed as nmol hydrolised substrate/min. **SL (sulphatides) concentration is expressed as μg/g of fresh tissue. SD: standard deviation
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Figure 1. Box-plot of Arylsulphatase A activity.
Box-plot of ASA activity in patients  with normal patterns (N), and with endometrial 
polyps (P). Data are presented as medians and limits. Median ASA value in 
patients with endometrial polyps was 1.85 nmol hydrolized substrate/min (limits: 
0.6–3.49). Median ASA value in patients with normal pattern was 2.62  nmol 
hydrolized substrate/min (limits: 2.28–3.23).
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Figure 2. Box-plot of Sulphatide concentration.
Box-plot of SL concentration in patients with normal patterns (N), and with 
endometrial polyps (P). Data are presented as medians and limits. Median SL 
concentration in patients with endometrial polyps was 1,031 μg/g of fresh tissue 
(limits:  263–1,081). Median SL concentration in patients with normal pattern was 
341.5 μg/g of fresh tissue (limits: 300–536).
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patients with the second endometrial sampling resulting 
in normal pattern (p=0.006).
Median SL concentration in patients with second 
endometrial sample resulting in normal pattern was 
341.5 μg/g of fresh tissue (limits: 300–536). Median SL 
concentration in patients with the second endometrial 
sample diagnosed with endometrial polyp was 1,031 μg/g 
of fresh tissue (limits:  263–1081). A box-plot describing 
SL concentrations in both group of patients is represented 
in Figure 2. Median SL concentration/years elapsed does 
not differ significantly between groups, even if the mean 
concentration of SL seems to be greater in patients who 
subsequently developed polyps. 
Discussion
Hyperestrogenism as the cause of endometrial pol-
yps is a common belief in the international literature3, 
even if the cause of the onset of endometrial polyp is still 
unknown15. It should be considered that tissue sensitiv-
ity to estrogens is related to the expression of estrogen 
receptors alpha and beta. As reported by Ye et al.16, the 
overexpression of estrogen receptor beta may lead to the 
formation of endometrial polyps. 
The expression of estrogen receptors is modulated 
by endometrial pulsed stimulation of estrogens in post-
menopause17. Moreover, aging alters estrogen sensitivity 
as well18-20. It is also reported16 that estrogen receptor 
beta is directly related to estrogen levels in serum. 
Therefore, hyperestrogenism could lead to the onset of 
endometrial polyps acting on the relative expression 
of estrogen receptor beta over the years. We hypothesize 
that ASA activity is linked with the overall effect of es-
trogen receptors beta, alpha, and progesterone receptors. 
A relative abundance of estrogen receptors beta physi-
ologically prevents the expression of estrogen receptor 
alpha and, consequently, of progesterone receptors21. 
Therefore, in patients that further develop endometrial 
polyps, a less intense activity of ASA should be found 
as a sign of less intense sensitivity to progesterone. The 
ASA activity reported in our data should be strictly 
related to estrogen receptor alpha/beta ratio. Therefore, 
ASA activity predicts the formation of endometrial 
polyps over the years, because a chronically irregular 
estrogen stimulation of the endometrium leads to the 
formation of endometrial polyps3. After correcting the 
ASA activity values by years elapsed from the first to the 
second endometrial sampling, it is demonstrated that 
ASA activity predicts the onset of endometrial polyps.
Interestingly, the SL concentration does not seem 
to be related to the formation of endometrial polyps. As 
demonstrated in Figure 2, however, data are dispersed, 
leading to difficulties to interprete the results. However, 
a dispersion of SL concentrations in decidua and fetal 
adnexa was previously found22,23, thus suggesting that the 
turnover of SL may be related to other control mechanisms 
involving both biosynthesis and catabolism. Therefore, 
steroids may control  the SL turnover in many unknown 
ways overall.
The major limitation of this study is the small sample 
of followed-up patients. Due to this small sample size, 
readers must be cautious to interprete the results as being 
conclusive. Moreover, the sample size may justify the lack 
of findings about the SL behaviour. We are not able to 
follow-up more patients, because the endometrial samples 
were collected with other goals, and, consequently, many 
patients were lost to follow-up. Therefore, readers should 
consider those findings as post-hoc results, suggesting 
further investigations about the behaviour of ASA in the 
pathophysiology of the human endometrium.  
Additionally, this study does not assess steroid 
receptor expression in relation to ASA activity and SL 
concentration behavior. This is a limiting factor if one 
wants to support the hormonal hypothesis of ASA activity 
control. We were unable to check the steroid receptors 
expression in the endometrial specimens. However, previ-
ous data widely suggested that ASA activity is enhanced 
by progesterone5,6,22,23. 
In conclusion, the results suggest that ASA activity 
may predict the formation of endometrial polyps over 
the years, because it is a marker of lack of endometrial 
progesterone sensitivity. 
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